By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market on Thursday a 22 percent drop year over year in fourth quarter revenues.

For the three months ended Dec. 31, 2010, the Omaha, Neb.-based firm reported revenues of $5.1 million, compared to $6.5 million a year ago. In a statement, the firm said that fourth-quarter 2009 figures included an "exceptionally large" order of Wave instruments for the detection of genetic variation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.